Drug intelligence / Profile preview

Wendanningxin

Development stage: Unknown
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

Wendanningxin is a Traditional Chinese Medicine (TCM) herbal granule developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is specifically formulated for the treatment of mild to moderate anxiety disorders, particularly those categorized under the 'heart gallbladder Qi deficiency' pattern in TCM. The formula is a refined version (Jingjian Recipe) of traditional decoctions, intended to regulate Qi, resolve phlegm, and calm the spirit (Ningxin). Clinical research on Wendanningxin focuses on its efficacy in reducing anxiety symptoms and its underlying mechanisms involving brain function and neural pathways.

Brand names: Wendanningxin granule
Other names: Wendanningxin granuleWendanningxin granule Jingjian Recipe

Beyond the preview

Go deeper on Wendanningxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wendanningxin.

Explore the full profile